An interventional study of Full-mouth ultrasonic debridement with piezoelectric device (EMS, mini piezon) and Full-mouth ultrasonic debridement with magnetostrictive device (Cavitron Select, Dentsply) in Periodontitis, Adult, sponsored by University of Siena. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-09-10.
Sponsored by University of Siena · Not applicable, Interventional, and Treatment
The treatment of periodontitis requires the removal of dental biofilm through both professional mechanical plaque removal and at-home oral hygiene practices. This study aims to compare clinical and psychological outcomes following professional treatment using either piezoelectric or magnetostrictive ultrasonic devices.
Patients diagnosed with periodontitis will be screened for eligibility criteria. A comprehensive full-mouth periodontal assessment will be conducted by a calibrated examiner to determine the severity and extent of the disease. Subsequently, patients will receive oral hygiene instructions, and group allocation will be revealed using a sealed envelope. Based on the assigned group, full-mouth ultrasonic debridement will be performed by a trained operator. Patient perceptions regarding the treatment will then be recorded. After three months, patients will return for a follow-up periodontal evaluation.
377 studies on the registry are indexed under Chronic Periodontitis; 21 are open to participants now.
This study's planned enrollment of 52 is above the median of 46 across 307 interventional studies indexed under Chronic Periodontitis.
Browse Chronic Periodontitis studies →University of Siena is the lead sponsor of 65 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Full-mouth ultrasonic debridement will be performed with a ultrasonic tip (vibration frequence \>18 kHz) powered by a piezoelectric device
Device: Full-mouth ultrasonic debridement with piezoelectric device (EMS, mini piezon)
Full-mouth ultrasonic debridement will be performed with a ultrasonic tip (vibration frequence \>18 kHz) powered by a magnetostrictive device.
Device: Full-mouth ultrasonic debridement with magnetostrictive device (Cavitron Select, Dentsply)
the use of ultrasonic oscillating tips allows supragingival and subgingival biofilm and dental calculus removal
the use of ultrasonic oscillating tips allows supragingival and subgingival biofilm and dental calculus removal
Pain perception
vas scale (0-10) for perception of pain after treatment
Time frame: through study completition, on average 6 months
noise
vas scale (0-10) for perception of noise after treatment
Time frame: through study completition, on average 6 months
vibration
vas scale (0-10) for perception of vibration after treatment
Time frame: through study completition, on average 6 months
pocket closure
change of pocket probing depth (millimeter) after treatment measured with a periodontal probe
Time frame: through study completition, on average 6 months
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2025 (actual). Primary completion is estimated for Oct 2025, 7 months after the start.
Of 88 non-industry interventional studies with no phase under Chronic Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 24. This study's planned 7 months is below that.
Counting every sponsor, half of 89 studies reached it within 15 months; a quarter within 10 and three quarters within 24.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Siena